The response to initial chemotherapy as a prognostic factor in localized Ewing's sarcoma

Odile Oberlin(Institut Gustave Roussy), French Society of Pediatric Oncol, François Deméocq, M Brunat-Mentigny(Centre Léon Bérard), Philippe Tron(Hôpital Charles-Nicolle), M. J. Lacombe(Institut Gustave Roussy), Jean Lemerle(Institut Gustave Roussy), Catherine Patte(Institut Gustave Roussy), B. Bui(Institut Bergonié), M.C. Demaille(Centre Oscar Lambret)
European Journal of Cancer and Clinical Oncology
April 1, 1985
10.1016/0277-5379(85)90038-0
Cited by 112

Related Papers

Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global Challenge
|Journal of Clinical Oncology|2015|450
Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients
|Blood|2006|431
SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease
|Neuro-Oncology|2013|371
Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents
|Blood|2006|362
Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies
|Journal of Allergy and Clinical Immunology|2017|316